Search
Patexia Research
Case number 1:21-cv-00283

Vanda Pharmaceuticals Inc. v MSN Pharmaceuticals Inc. et al > Documents

Date Field Doc. No.Description (Pages)
Jan 19, 2022 N/A Terminated Case (0)
Docket Text: CASES CLOSED per the CONSENT JUDGMENT AND PERMANENT INJUNCTION FILED IN CIV. NO. 18-651-CFC. Associated Cases: 1:19-cv-00926-CFC, 1:20-cv-00235-CFC, 1:20-cv-00318-CFC, 1:20-cv-01334-CFC, 1:21-cv-00283-CFC(nmf)
Apr 26, 2021 24 SO ORDERED (5)
Docket Text: SO ORDERED, re (21 in 1:21-cv-00121-CFC, 23 in 1:21-cv-00283-CFC, 227 in 1:18-cv-00651-CFC, 20 in 1:21-cv-00282-CFC) Stipulation and Order for Consolidation filed by Vanda Pharmaceuticals Inc. ALL FUTURE FILINGS SHALL BE MADE IN THE LEAD CONSOLIDATED ACTION, C.A. NO. 18-651-CFC. Signed by Judge Colm F. Connolly on 4/26/2021. Associated Cases: 1:18-cv-00651-CFC, 1:21-cv-00121-CFC, 1:21-cv-00282-CFC, 1:21-cv-00283-CFC(fms)
Apr 26, 2021 N/A Remark (0)
Docket Text: Remark: ALL FUTURE FILINGS SHALL BE MADE IN THE LEAD CONSOLIDATED ACTION, C.A. NO. 18-651-CFC. Associated Cases: 1:21-cv-00121-CFC, 1:21-cv-00282-CFC, 1:21-cv-00283-CFC(fms)
Apr 26, 2021 N/A Create Case Association (0)
Docket Text: Case associated with lead case: Create association to 1:18-cv-00651-CFC. (fms)
Apr 21, 2021 23 Stipulation (5)
Docket Text: Proposed STIPULATION and Order for Consolidation by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek)
Apr 20, 2021 22 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Vanda Pharmaceuticals Inc.'s Intrinsic Evidence Supporting Claim Construction for Wave 3 Patents filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen)
Apr 16, 2021 20 Order (2)
Docket Text: ORDER: IT IS ORDERED that, on or before May 17, 2021, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 5/17/2021.) Signed by Judge Colm F. Connolly on 4/16/2021. Associated Cases: 1:21-cv-00121-CFC, 1:21-cv-00282-CFC, 1:21-cv-00283-CFC(nmf)
Apr 16, 2021 21 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of MSN's Responses and Objections to Vanda's First Interrogatory to MSN (No. 1) Regarding U.S. Patent Nos. 10,610,510, 10,610,511, 10,829,465 and 10,611,744 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David)
Apr 12, 2021 19 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Plaintiff Vanda Pharmaceuticals Inc.'s Proposed Claims and Constructions for Wave 3 Patents filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen)
Apr 9, 2021 18 Answer to Counterclaim (12)
Docket Text: ANSWER to [14] Answer to Amended Complaint, Counterclaim by Vanda Pharmaceuticals Inc..(Fahnestock, Derek)
Apr 7, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [17] MOTION for Pro Hac Vice Appearance of Attorney Kevin E. Warner filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 4/7/2021. (fms)
Apr 5, 2021 17 Main Document (1)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kevin E. Warner - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # (1) Warner Pro Hac Certification)(Bilson, David)
Apr 5, 2021 17 Warner Pro Hac Certification (1)
Apr 1, 2021 16 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by David A. Bilson on behalf of MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. (Bilson, David)
Mar 26, 2021 14 Answer to Amended Complaint (30)
Docket Text: ANSWER to Amended Complaint, re: [10] Amended Complaint Affirmative Defenses, COUNTERCLAIM against Vanda Pharmaceuticals Inc. by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Phillips, John)
Mar 26, 2021 15 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Limited for MSN Pharmaceuticals Inc. filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Phillips, John)
Mar 17, 2021 13 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Vanda's First Interrogatory to MSN (No. 1) Regarding U.S. Patent Nos. 10,610,510; 10,610,511; 10,829,465; and 10,611,744 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek)
Mar 15, 2021 12 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of (1) Vanda's Disclosure of Asserted Claims and Contentions Regarding Infringement by MSN of U.S. Patent Nos. 10,610,510 and 10,610,511, (2) Vanda's Disclosure of Asserted Claims and Contentions Regarding Infringement by MSN of U.S. Patent Nos. 10,829,465 and 10,611,744, and (3) Disclosure of Accused Products and the Asserted Patents and Claims for U.S. Patent Nos. 10,610,510, 10,610,511, 10,829,465 and 10,611,744 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek)
Mar 12, 2021 10 Amended Complaint* (1)
Mar 12, 2021 10 Main Document (25)
Docket Text: First AMENDED COMPLAINT for Patent Infringement against MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.- filed by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Exhibits A-B)(Fahnestock, Derek)
Mar 12, 2021 10 Exhibits A-B (22)
Mar 12, 2021 11 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,829,465 B2 ;10,611,744 B2 (Amended). (Fahnestock, Derek)
Mar 4, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (7 in 1:21-cv-00283-CFC, 9 in 1:21-cv-00282-CFC) MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Josephine Young, Daniel J. Klein, Jennifer Rea Deneault & Michael F. Milea filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 3/4/2021. Associated Cases: 1:21-cv-00282-CFC, 1:21-cv-00283-CFC(nmf)
Mar 3, 2021 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:21-cv-00282-CFC, 1:21-cv-00283-CFC (rjb)
Mar 1, 2021 7 Motion for Leave to Appear Pro Hac Vice (10)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Josephine Young, Daniel J. Klein, Jennifer Rea Deneault & Michael F. Milea - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek)
Mar 1, 2021 8 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Vanda Pharmaceuticals Inc.. MSN Laboratories Private Limited served on 2/26/2021, answer due 3/19/2021. (Fahnestock, Derek)
Mar 1, 2021 9 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Vanda Pharmaceuticals Inc.. MSN Pharmaceuticals Inc. served on 2/26/2021, answer due 3/19/2021. (Fahnestock, Derek)
Feb 25, 2021 6 Summons Issued - Electronic (2)
Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (amf)
Feb 24, 2021 1 Main Document (13)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3544087.) - filed by Vanda Pharmaceuticals Inc. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(amf)
Feb 24, 2021 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Blackrock for Vanda Pharmaceuticals Inc. - filed by Vanda Pharmaceuticals Inc. (amf)
Feb 24, 2021 4 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/21/2021. Date of Expiration of Patent: 2/12/2035.Thirty Month Stay Deadline: 7/31/2021. (amf)
Feb 24, 2021 3 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,829,465 B2. (amf)
Feb 24, 2021 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (amf)
Feb 24, 2021 1 Civil Cover Sheet (2)
Feb 24, 2021 1 Exhibit A (11)
Feb 24, 2021 1 Complaint* (1)
Menu